Document is current

Any future updates will be listed below

Targeting the PI3K/AKT/mTOR signaling pathway in prostate cancer: Molecular dysregulation, therapeutic advances, and future directions

Crossref DOI link: https://doi.org/10.1007/s44446-025-00056-w

Published Online: 2026-01-12

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark